Sorry, you need to enable JavaScript to visit this website.
Home About Responsibility Global Impact An Accord for a Healthier World

An Accord for a Healthier World

An Accord for a Healthier World seeks to close the health equity gap for 1.2 billion people living in 45 lower-income countries around the world by addressing systemic barriers that delay, limit or prevent access to innovative medicines and vaccines. 

Because where you live shouldn’t impact the quality of your healthcare, and your income shouldn’t determine your health outcomes. 

Explore how An Accord for a Healthier World is working to close the health equity gap.

  • An Accord for a Healthier World is a first-of-its-kind initiative to enable sustained, equitable access to high-quality, safe, and effective medicines and vaccines with the potential to improve the health of 1.2 billion people living in lower-income countries around the world. 

    Through the Accord, we have committed to provide Pfizer’s patent-protected medicines and vaccines available in the U.S. or European Union on a not-for-profit basis to 45 lower-income countries around the world. By doing so, we aim to provide breakthrough prevention and treatment options for millions of people impacted by deadly infectious diseases like COVID-19 and pneumonia, as well as certain cancers and rare and inflammatory diseases. As we launch new medicines and vaccines, those products will also be included in the Accord portfolio on a not-for-profit basis. 

  • Rwanda, Ghana, Malawi, Senegal, and Uganda are the first five countries to commit to join the Accord, which will identify early insights to ensure all medicines and vaccines can reach those in need. The learnings from these five countries will be shared across all 45 countries, which are home to 1.2 billion people.

  • This transformational commitment has the potential to provide lifesaving treatment for diseases that claim the lives of nearly one million people each year and to support better health for at least half a million more suffering from chronic diseases.1 

  • Accord partners will work together with Pfizer to identify quick and efficient regulatory pathways and procurement processes to reduce the amount of time it can take to make new medicines and vaccines available in these countries. Additionally, we will work closely with healthcare officials in Rwanda, Ghana, Malawi, Senegal, and Uganda to identify opportunities to support improved diagnosis, healthcare professional education, and training, along with supply chain management and other infrastructure enhancements. Learnings will be shared across all Accord countries to help speed sustainable access.

  • Under the Accord, and with funding from the Bill & Melinda Gates Foundation, Pfizer is advancing the development of vaccine candidates for the prevention of Group B Streptococcus—a leading cause of stillbirth and newborn mortality in low-income countries. Pfizer is also exploring opportunities to support other maternal vaccines, including Respiratory Syncytial Virus (RSV) vaccine development.

  • The patent-protected medicines and vaccines made available through the Accord help to treat and prevent infectious diseases including COVID-19, pneumonia, and meningitis. They help to treat certain cancers including types of leukemia, breast cancer, and advanced kidney cancer. And they manage inflammatory and rare diseases.

Countries in An Accord for a Healthier World


Patient incomes shouldn’t affect health outcomes. And geography shouldn’t impact quality of care.

Through this initiative, we have committed to provide all current and future patent-protected Pfizer medicines and vaccines available in the U.S. or European Union on a not-for-profit basis to 45 lower-income countries around the world.

The Accord partners are calling upon global health leaders and organizations to join us in enabling an environment that strengthens healthcare systems and provides speedy access to life-saving medicines and vaccines to address the global health equity gap.

Opening quote
As we learned in the global COVID-19 vaccine rollout, supply is only the first step to helping patients. We will work closely with global health leaders to make improvements in diagnosis, education, infrastructure, storage, and more. Only when all the obstacles are overcome can we end healthcare inequities and deliver for all patients.
Closing quote

Albert Bourla, Pfizer Chairman and CEO

Opening quote
Everyone, no matter where they live, should have the same access to innovative, life-saving drugs and vaccines. An Accord for a Healthier World could help millions more people in low-income countries get the tools they need to live a healthy life. Pfizer is setting an example for other companies to follow.
Closing quote

Bill Gates, Co-Chair of the Bill & Melinda Gates Foundation

Opening quote
Rapid and affordable access to the most advanced medicines and vaccines is the cornerstone of global health equity. Pfizer’s commitment under the Accord program sets a new standard in this regard. Combined with additional investments in strengthening Africa’s public health systems and pharmaceutical regulators, the Accord is an important step toward sustainable health security for countries at every income level.
Closing quote

His Excellency Paul Kagame, President of Rwanda

Opening quote
We must continue to strive for quality healthcare for all people to live longer, stronger and healthier lives. It will require strong cooperation between the public and private sectors. We are proud to join this Accord to work together on this important goal.
Closing quote

His Excellency President Nana Addo Dankwa Akufo-Addo, President of Ghana

Opening quote
Senegal proudly supports the launch of An Accord for a Healthier World to improve health equity and outcomes for the people of our country and across the world. Together, we will work for a better world.
Closing quote

His Excellency Macky Sall, President of Senegal

Opening quote
The great thing about this Accord is that it helps low-income countries without violating their dignity and agency as people, for it is a true partnership that involves both Pfizer and countries like Malawi sharing the burden of costs and tasks in the production and delivery of supplies that will save millions of lives. This is how all global problems should be tackled.
Closing quote

His Excellency Lazarus Chakwera, President of Malawi

Opening quote
It is the time to close the health equity gap. Uganda is proud to join the Accord, and we are committed to working with Pfizer and all Accord partners to find new ways to address access challenges.
Closing quote

His Excellency Yoweri Museveni, President of Uganda

1 Internal calculations based on data collected via